CARM

Carisma Therapeutics (CARM)

Carisma Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CARM

<< 이전 1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/09/01	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CARM	Carisma Therapeutics Inc
2023/09/01	21:30	PR Newswire (US)	Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit	NASDAQ:CARM	Carisma Therapeutics Inc
2023/08/24	21:30	PR Newswire (US)	Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/08/11	02:44	PR Newswire (US)	Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights	NASDAQ:CARM	Carisma Therapeutics Inc
2023/08/10	21:36	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CARM	Carisma Therapeutics Inc
2023/08/10	20:36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CARM	Carisma Therapeutics Inc
2023/08/04	00:45	Business Wire	Carmila : Cession d’un actif en France pour 35 millions d’euros	NASDAQ:CARM	Carisma Therapeutics Inc
2023/08/04	00:45	Business Wire	Carmila: Asset Sale in France for €35 Million	NASDAQ:CARM	Carisma Therapeutics Inc
2023/08/02	00:55	Business Wire	CARMILA: Information Concerning the Total Number of Voting Rights and Share, Provided Pursuant to Article L.233-8 II of the Code de commerce (French Commercial Code) and Article 223-16 of the Règlement général de l’Autorité des marchés financiers	NASDAQ:CARM	Carisma Therapeutics Inc
2023/08/02	00:55	Business Wire	CARMILA : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiers	NASDAQ:CARM	Carisma Therapeutics Inc
2023/07/26	01:52	Business Wire	Carmila : Mise à disposition du rapport financier semestriel 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/07/26	01:52	Business Wire	Carmila: 2023 Half-Year Financial Report Available	NASDAQ:CARM	Carisma Therapeutics Inc
2023/07/26	00:45	Business Wire	CARMILA : Résultats du premier semestre 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/07/26	00:45	Business Wire	Carmila: 2023 Half-Year Results	NASDAQ:CARM	Carisma Therapeutics Inc
2023/07/13	01:59	Business Wire	Carmila : Accord en vue d’acquérir Galimmo SCA	NASDAQ:CARM	Carisma Therapeutics Inc
2023/07/13	01:59	Business Wire	Carmila: Agreement to acquire Galimmo SCA	NASDAQ:CARM	Carisma Therapeutics Inc
2023/07/08	00:50	Business Wire	CARMILA: Resources devoted to the liquidity contract as of 30 June 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/07/08	00:50	Business Wire	Carmila : Moyens portés au contrat de liquidité au 30 juin 2023	NASDAQ:CARM	Carisma Therapeutics Inc
2023/07/05	00:51	Business Wire	CARMILA: Information Concerning the Total Number of Voting Rights and Share	NASDAQ:CARM	Carisma Therapeutics Inc
2023/07/05	00:51	Business Wire	CARMILA : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiers	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/28	21:30	PR Newswire (US)	Carisma Therapeutics Announces First Patient Dosed in Phase 1 Study of CT-0508 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2 Overexpressing Solid Tumors	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/26	21:30	PR Newswire (US)	Carisma Therapeutics to be Added to Russell 2000®, Russell 3000® and Russell Microcap® Indexes	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/14	21:30	PR Newswire (US)	Carisma Therapeutics Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/09	07:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/09	07:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/09	07:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/09	07:15	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/09	07:14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/09	07:11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CARM	Carisma Therapeutics Inc
2023/06/06	00:45	Business Wire	Carmila: Information concerning the total number of voting rights and share, provided pursuant to article L.233-8 II of the Code de commerce (French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des marchés financiers	NASDAQ:CARM	Carisma Therapeutics Inc